Even as the tech industry continues to grapple with the prolonged funding winter, biotech startups in Southeast Asia have proved to be an outlier this year. 2023 has also seen a few big funds being launched focusing on the biotech and life science sectors, signalling strong investor appetite in the industry.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
